StonvexLoading…
StonvexStonvexStonvexCore line items from PSIX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $722.40M | $475.97M | $458.97M | $481.33M |
Operating Income | $109.71M | $81.64M | $44.27M | $24.60M |
Net Income | $113.99M | $69.28M | $26.31M | $11.27M |
EPS (Diluted) | $4.94 | $3.01 | $1.15 | $0.49 |
Total Assets | $424.75M | $328.18M | $284.30M | $319.91M |
Total Liabilities | $246.14M | $262.93M | $288.22M | $350.29M |
Cash & Equivalents | $41.25M | $55.25M | $22.76M | $24.30M |
Free Cash Flow OCF − CapEx | $14.14M | $57.83M | $65.48M | $-10.20M |
Shares Outstanding | 23.04M | 23.00M | 22.97M | 22.95M |